28.04.2022 - PARIS, April 28, 2022 (GLOBE NEWSWIRE) - Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal products that act directly on the brain in order to address . Seite 1
Quantum Genomics Publishes its Results for Fiscal Year 2021 and Provides a Corporate Update apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Update of Shareholding Situation Following April 27, 2022 Capital Raise
Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a
Quantum Genomics announces successful capital raising with a gross sum of approximately €15.6 M€ Quantum Genomics has equipped itself with new financial means to pursue the development of firibastat
Quantum Genomics Raises a Gross Amount of Approximately € 15 M Launch of capital increase of approximately €15 million for institutional investors with cancellation of the pre-emptive subscription